ZEVENBERGEN CAPITAL INVESTMENTS LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
ZEVENBERGEN CAPITAL INVESTMENTS LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$42,450,000
-27.0%
369,325
-0.8%
1.84%
-26.0%
Q3 2014$58,164,000
+34.9%
372,275
+6.5%
2.48%
+63.9%
Q2 2014$43,128,000
+6.2%
349,640
-10.8%
1.52%
+4.2%
Q1 2014$40,620,000
-0.5%
392,050
-13.7%
1.46%
+3.3%
Q4 2013$40,842,000
+19.0%
454,100
-11.5%
1.41%
+21.4%
Q3 2013$34,323,000
-17.2%
513,200
-18.1%
1.16%
-30.8%
Q2 2013$41,463,000626,8001.68%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Verition Fund Management LLC 2,787,800$481,760,00055.98%
Brenner West Capital Advisors 1,800,000$311,058,00028.01%
FNY Managed Accounts LLC 180,357$31,167,493,00025.70%
Twin Securities, Inc. 1,189,192$205,505,00024.16%
FIRST NEW YORK SECURITIES LLC /NY 98,099$16,952,488,00016.70%
HARVEST MANAGEMENT LLC 77,500$13,393,00014.40%
Tyrus Capital S.A.M. 687,800$118,859,00013.24%
BARDIN HILL MANAGEMENT PARTNERS LP 472,550$81,661,00011.65%
ARGENTIERE CAPITAL AG 151,500$26,181,00010.81%
Sachem Head Capital 725,000$125,425,0008.31%
View complete list of SALIX PHARMACEUTICALS INC shareholders